Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis. (Q45937899)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis.	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7818255

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/7818255

title

Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7818255

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/7818255

main subject

multiple sclerosis

0 references

methotrexate

1 reference

based on heuristic

inferred from title

author name string

Goodkin DE

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7818255

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/7818255

Rudick RA

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7818255

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/7818255

VanderBrug Medendorp S

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7818255

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/7818255

Daughtry MM

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7818255

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/7818255

Schwetz KM

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7818255

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/7818255

Fischer J

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7818255

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/7818255

Van Dyke C

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7818255

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/7818255

publication date

1 January 1995

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7818255

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/7818255

published in

Annals of Neurology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7818255

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/7818255

volume

37

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7818255

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/7818255

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7818255

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/7818255

page(s)

30-40

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7818255

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/7818255

cites work

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FANA.410370108

retrieved

21 January 2018

Corpus callosotomy for epilepsy. II. Neurologic and neuropsychological outcome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FANA.410370108

retrieved

21 January 2018

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FANA.410370108

retrieved

21 January 2018

Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Multiple Sclerosis Collaborative Research Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FANA.410370108

retrieved

21 January 2018

Magnetic resonance imaging lesion enlargement in multiple sclerosis. Disease-related activity, chance occurrence, or measurement artifact?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FANA.410370108

retrieved

21 January 2018

Identifiers

DOI

10.1002/ANA.410370108

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7818255

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/7818255

PubMed publication ID

7818255

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7818255

retrieved

18 December 2017

reference URL

http://europepmc.org/abstract/MED/7818255

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45937899&oldid=1568029367"